A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

NCT05726682 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision to cancel trial, not related to safety concern.

Conditions

Allogenic Stem Cell Transplantation

Interventions

DRUG: SAR445419

Sponsor

Sanofi